Background. Extemporaneous compounding is a pharmacy practice to produce suitable
pharmaceutical preparations when there are no commercially available, licensed, and age …

Background: Type 2 diabetes (T2D) is one of the leading causes of mortality and is a public
health challenge worldwide. Metformin is the first-choice treatment for T2D; its …

The use of unlicensed and off-label medicines in children is widespread and has raised an
increasing concern over the last years. The majority of medicines taken by children are …

Genetic factors that affect variability in metformin response have been poorly studied in the
Latin American population, despite its being the initial drug therapy for type 2 diabetes, one …

Metformin pharmacokinetics in a liquid extemporaneous formulation from commercial tablets
was determined in paediatric patients. A randomized, transversal clinical trial was conducted …

Background. Type II diabetes mellitus is a chronic disease with a high prevalence worldwide
and metformin is the first line oral antidiabetic therapy for its treatment. The possible …

The complex syndrome of obesity is a complex syndrome associated with various metabolic
disorders, poses significant threats to human health. Many weight loss medications have the …

The safety and quality of pharmaceutical products can be affected by chemical contaminants
that migrate into them, depending on the type and composition of the packaging material …

The complex syndrome of obesity is a complex syndrome associated with various metabolic
disorders, poses significant threats to human health. Many weight loss medications have the …

ANTECEDENTES: fraccionar o pulverizar tabletas de metformina para ajustar dosis
pediátricas dificulta su administración, genera inestabilidad del fármaco (oxidación …